Back to Search Start Over

Intrathecal production of interleukin-12 and gamma-interferon in patients with bacterial meningitis

Authors :
Kornelisse, R.F.
Hack, C.E.
Savelkoul, H.F.J.
van der Pouw-Kraan, T.C.T.M.
Hop, W.C.J.
van Mierlo, G.
Suur, M.H.
Neijens, H.J.
de Groot, R.
Source :
Infection and Immunity 65 (1997) 3, Infection and Immunity, 65(3), 877-881
Publication Year :
1997

Abstract

To assess the role of interleukin-12 (IL-12) and gamma interferon (IFN-gamma) in children with bacterial meningitis, bioactive IL-12 (p70) and the inactive subunit p40 and IFN-gamma were measured in serum and cerebrospinal fluid (CSF) from 35 children with bacterial meningitis and 10 control subjects. The production of IFN-gamma is induced by IL-12 with tumor necrosis factor alpha (TNF-alpha) as a costimulator and inhibited by IL-10. CSF concentrations of IL-12 p40 as well as those of IFN-gamma were markedly elevated, whereas IL-12 p70 was hardly detectable. Detectable CSF levels of IFN-gamma correlated positively with IL-12 p40 (r = 0.40, P = 0.02) and TNF-alpha (r = 0.46, P = 0.04) but not with IL-6, IL-8, or IL-10. In contrast to CSF levels of TNF-alpha, IL-12, and IL-10, those of IFN-gamma were significantly higher in patients with pneumococcal meningitis than in children with meningitis caused by Haemophilus influenzae and Neisseria meningitidis, presumably because of a high CSF TNF-alpha/IL-10 ratio in the former. We suggest that IL-12- and TNF-alpha-induced IFN-gamma production may contribute to the natural immunity against microorganisms in the CSF compartment during the acute phase of bacterial meningitis. -------------------------------------------------------------------------------- Write to PMC | PMC Home | PubMed NCBI | U.S. National Library of Medicine NIH | Department of Health and Human Services Privacy Policy | Disclaimer | Freedom of Information Act

Subjects

Subjects :
Life Science

Details

Language :
English
ISSN :
00199567
Database :
OpenAIRE
Journal :
Infection and Immunity 65 (1997) 3, Infection and Immunity, 65(3), 877-881
Accession number :
edsair.dedup.wf.001..7669db44b3bc39f198b936c968c203d5